Related Experiment Videos
Optimal haloperidol dosage in first-episode psychosis
J Zhang-Wong1, R B Zipursky, M Beiser
1Centre for Addiction and Mental Health, Clarke Division, Toronto, Ontario. Joey.Wong@utoronto.ca
Summary
Lower doses of haloperidol effectively treat first-episode psychosis. Many patients respond to doses below those commonly prescribed, indicating a need for personalized treatment strategies for psychosis.
Area of Science:
- Psychiatry
- Pharmacology
- Clinical Medicine
Background:
- First-episode psychosis (FEP) requires effective and safe treatment.
- Haloperidol is a commonly used antipsychotic, but optimal dosing for FEP is debated.
- Determining optimal haloperidol doses can improve treatment outcomes and minimize side effects.
Purpose of the Study:
- To identify the optimal dosage range of haloperidol for individuals experiencing their first episode of psychosis.
- To compare treatment efficacy and side effect profiles across different haloperidol doses.
Main Methods:
- A 4-week prospective controlled clinical trial was conducted.
- Optimal haloperidol dose was defined by either significant improvement (≥15% decrease in PANSS scores) or onset of extrapyramidal symptoms.
- Doses started at 2 mg/day and increased weekly to 5 mg, 10 mg, and 20 mg/day.
Main Results:
- Optimal haloperidol doses varied among 36 subjects: 2 mg/day (n=15), 5 mg/day (n=11), 10 mg/day (n=7), and 20 mg/day (n=3).
- Subjects with an optimal dose of 2 mg/day showed the greatest average improvement.
- Of 27 responders, 20 had plasma haloperidol levels below 5 ng/ml.
Conclusions:
- Many patients with first-episode psychosis respond to haloperidol doses significantly lower than typically used.
- Lower haloperidol doses may be sufficient for effective treatment, potentially reducing adverse effects.
- Individualized dosing based on clinical response and symptom severity is recommended for FEP treatment.